Dr James Wilmott awarded for outstanding cancer research
6 August 2016
Research Associate at Melanoma Institute Australia, Dr James Wilmott, was awarded the Wildfire Award at last night's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The 'Wildfire' Highly Cited Publication Award is given to a NSW researcher who has made a significant difference to cancer research, care or practice through authoring a highly cited publication that is expected to significantly influence cancer control or further research.
His publication ‘Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma external’ is being used by pathology departments around the world to triage patients into lifesaving personalised medicines.
Some patients only have days to live without intervention and cannot wait for routine molecular testing results.
The assay described in the publication allows patients who could die waiting to be tested and treated with lifesaving drugs.
Dr Wilmott has authored more than 50 manuscripts which have been cited over 1400 times. His research interests are biomarker studies of patients treated with targeted therapies and he is currently working as the Project Manager for the Australian Melanoma Genome Project.
As part of the prestigious award, Dr Wilmott will be granted $20,000 to future research endeavours.
Previous winners of the Wildfire Award from MIA include Prof Georgina Long (in 2014) and A/Prof Pascale Guitera (in 2013).
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.
Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.
Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.
‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.’
The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma
A prestigious $10 million Australian Cancer Research Foundation grant has been awarded to ACEMID, an initiative that aims to use 3D total-body imaging and a remote medicine network to improve the detection and diagnosis of early-stage melanoma.